Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Milestone Pharmaceuticals Inc (NQ: MIST )

7.670 +0.420 (+5.79%)
Official Closing Price Updated: 5:59 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 107,600
Open 7.180
Bid (Size) 7.220 (1)
Ask (Size) 7.920 (1)
Prev. Close 7.250
Today's Range 7.116 - 7.730
52wk Range 1.690 - 23.25
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto,... 
From PR Newswire
Milestone Pharmaceuticals Announces First Patient Enrolled in RAPID, a Pivotal Phase 3 Study of Etripamil in PSVT
Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that the first... 
From PR Newswire

Performance

YTD
+13.46%
+13.46%
1 Month
+10.68%
+10.68%
3 Month
+9.57%
+9.57%
6 Month
-13.92%
-13.92%
1 Year
-64.64%
-64.64%

More News

Read More
Milestone Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Corporate Update
From PR Newswire
Milestone Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
From PR Newswire
Milestone Pharmaceuticals Announces Pricing of a Public Offering of $45 Million of Common Shares and Pre-Funded Warrants
From PR Newswire
Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
From PR Newswire
Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments
From PR Newswire
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
From PR Newswire
Milestone Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Corporate Update
From PR Newswire
12 Healthcare Stocks Moving In Tuesday's After-Market Session
Tags ZYXI HTGM EVFM
From Benzinga
Milestone Pharmaceuticals is Now Oversold (MIST)
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.